Showing results (201-210 of 319) with videos related to

Sort By:
Pageof 32
Cancers|June 10, 2022
Tropomyosin-Related Kinase Fusions in Gastrointestinal Stromal TumorsJi Hyun Lee, Su-Jin Shin, Eun-Ah Choe, et al.
Annals of Nuclear Medicine|February 4, 2016
Prognostic value of (18)F-fluorodeoxyglucose positron emission tomography in patients with gastric neuroendocrine carcinoma and mixed adenoneuroendocrine carcinomaSun Min Lim, Hyunki Kim, Beodeul Kang, et al.
Cancer Research and Treatment|August 27, 2009
Prognosis of pN3 stage gastric cancerJung Ryun Ahn, Minkyu Jung, Chan Kim, et al.
Investigational New Drugs|April 10, 2014
Combination of docetaxel and TSU-68, an oral antiangiogenic agent, in patients with metastatic breast cancer previously treated with anthracycline: randomized phase II multicenter trialSung-Bae Kim, Changhoon Yoo, Jungsil Ro, et al.
Cancer Research and Treatment|July 22, 2015
Circulating Plasma Biomarkers for TSU-68, an Oral Antiangiogenic Agent, in Patients with Metastatic Breast CancerChanghoon Yoo, Sung-Bae Kim, Jungsil Ro, et al.
The Oncologist|June 22, 2014
Quality of life in the trastuzumab for gastric cancer trialTaroh Satoh, Yung-Jue Bang, Evgeny A Gotovkin, et al.
Cancer Research and Treatment|May 2, 2024
Varlitinib and Paclitaxel for EGFR/HER2 Co-expressing Advanced Gastric Cancer: A Multicenter Phase Ib/II Study (K-MASTER-13)Dong-Hoe Koo, Minkyu Jung, Yeul Hong Kim, et al.
Cancer Research and Treatment|April 20, 2019
Temsirolimus in Asian Metastatic/Recurrent Non-clear Cell Renal CarcinomaJii Bum Lee, Hyung Soon Park, Sejung Park, et al.
Cancer Research and Treatment|July 4, 2023
First-in-Human Phase 1 Study of a B Cell- and Monocyte-Based Immunotherapeutic Vaccine against HER2-Positive Advanced Gastric CancerMinkyu Jung, Jii Bum Lee, Hyo Song Kim, et al.
Investigational New Drugs|December 29, 2010
A Phase Ib pharmacokinetic study of the anti-angiogenic agent CKD-732 used in combination with capecitabine and oxaliplatin (XELOX) in metastatic colorectal cancer patients who progressed on irinotecan-based chemotherapySang Joon Shin, Joong Bae Ahn, Kyung Soo Park, et al.
Pageof 32